Peipei Wang

2.0k total citations
67 papers, 1.2k citations indexed

About

Peipei Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Peipei Wang has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Peipei Wang's work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (6 papers). Peipei Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (6 papers). Peipei Wang collaborates with scholars based in China, United States and Serbia. Peipei Wang's co-authors include Yueyun Chen, Chaorong Li, Jingjing Wang, Yingying Zheng, Panhong Wang, Jiaqi Pan, Qi Yu, Changsheng Song, Chun Wang and Zhenyu Ding and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Peipei Wang

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peipei Wang China 19 444 311 285 274 158 67 1.2k
Haochen Yu China 18 200 0.5× 136 0.4× 468 1.6× 276 1.0× 83 0.5× 54 1.2k
Zhanzhao Fu China 20 179 0.4× 196 0.6× 450 1.6× 129 0.5× 84 0.5× 55 995
Min-Jung Kim South Korea 18 289 0.7× 99 0.3× 453 1.6× 127 0.5× 88 0.6× 28 988
Hongliang Yu China 19 205 0.5× 95 0.3× 602 2.1× 98 0.4× 152 1.0× 54 1.2k
Huizhen Zhang China 19 120 0.3× 214 0.7× 338 1.2× 194 0.7× 71 0.4× 39 933
Shuang Zhou China 18 288 0.6× 52 0.2× 377 1.3× 219 0.8× 230 1.5× 35 1.1k
Dongha Kim South Korea 13 138 0.3× 120 0.4× 524 1.8× 139 0.5× 80 0.5× 25 974
Michael J. Lukey United States 15 245 0.6× 379 1.2× 1.3k 4.5× 116 0.4× 177 1.1× 21 2.2k
Paloma Navarro Spain 20 235 0.5× 94 0.3× 549 1.9× 416 1.5× 65 0.4× 54 1.6k

Countries citing papers authored by Peipei Wang

Since Specialization
Citations

This map shows the geographic impact of Peipei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peipei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peipei Wang more than expected).

Fields of papers citing papers by Peipei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peipei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peipei Wang. The network helps show where Peipei Wang may publish in the future.

Co-authorship network of co-authors of Peipei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Peipei Wang. A scholar is included among the top collaborators of Peipei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peipei Wang. Peipei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Guodong, Yicheng Ma, Hang Dong, et al.. (2025). Association of serum 25-hydroxyvitamin D with the risk of depression in individuals with prediabetes and diabetes: A prospective cohort study. The journal of nutrition health & aging. 29(6). 100556–100556.
2.
Liu, Xia, Biwen Wu, Jiajun Li, et al.. (2025). AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers. International Immunopharmacology. 149. 114215–114215. 3 indexed citations
3.
Zhang, Yajun, Peipei Wang, Xiying Shao, et al.. (2025). Effects of Electroacupuncture and Mecobalamin for Utidelon-Induced Peripheral Neuropathy in Breast Cancer Patients: A Randomized Controlled Clinical Trial. Journal of Pain Research. Volume 18. 3593–3608. 2 indexed citations
4.
Wang, Peipei, Yu Liu, & Yuanjun Wang. (2025). Prediction Crohn's Disease Activity Using Computed Tomography Enterography-Based Radiomics and Serum Markers. Academic Radiology. 32(11). 6579–6590.
5.
Wang, Peipei, Cong Dai, Jinyi Liu, et al.. (2024). Increased co-expression of CTLA4/LAG3 predicted adverse clinical outcomes in patients with T-cell malignancies. 1(1). 100004–100004. 9 indexed citations
6.
Wang, Xiaoxiao, Peipei Wang, Li Zhao, et al.. (2024). The relationship between trajectories of renal oxygen saturation and acute kidney injury: a prospective cohort study with a secondary analysis. Aging Clinical and Experimental Research. 36(1). 46–46. 3 indexed citations
7.
Wang, Peipei, et al.. (2024). Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer. Medical Oncology. 41(4). 85–85. 2 indexed citations
8.
Liu, Xia, Peipei Wang, & Guolong Liu. (2024). NRI and SIRI are the optimal combinations for prognostic risk stratification in patients with non-small cell lung cancer after EGFR-TKI therapy. Clinical & Translational Oncology. 27(4). 1529–1538. 3 indexed citations
9.
Li, Qing, Hao Zeng, Ting Liu, et al.. (2024). A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice. Nature Communications. 15(1). 10419–10419. 4 indexed citations
10.
Wang, Yingying, Hong‐Xu Chen, Jingchun Liu, et al.. (2024). Static and dynamic interactions within the triple-network model in stroke patients with multidomain cognitive impairments. NeuroImage Clinical. 43. 103655–103655. 2 indexed citations
11.
12.
13.
Li, Yan, Xiaoqin Wu, Yongfeng Song, et al.. (2023). The short- and long-term readmission of four major categories of digestive system cancers: does obesity or metabolic disorder matter?. Frontiers in Endocrinology. 14. 1214651–1214651. 2 indexed citations
14.
Pang, Yizhen, et al.. (2023). Identification of isolated hepatic sarcoidosis with [18F]FDG and [68 Ga]Ga-FAPI PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2918–2919. 2 indexed citations
15.
Leng, Xiaohong, et al.. (2023). Effects of platelets on characteristics of lymphocytes cultured <i>in vitro</i> and optimization of adoptive immunotherapy. Biocell. 47(12). 2661–2669. 5 indexed citations
16.
Fu, Yang, Yue Zheng, Peipei Wang, Yueyun Chen, & Zhenyu Ding. (2022). Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient. Frontiers in Pharmacology. 13. 817265–817265. 7 indexed citations
17.
Xu, Mengxin, Junyi Chen, Jie Ding, et al.. (2020). PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a 177Lu-labeled αPD-L1 antibody. Theranostics. 11(1). 304–315. 25 indexed citations
18.
Lü, Lin, Huan Du, Chenxi Wang, et al.. (2020). CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells. International Journal of Medical Sciences. 17(7). 912–920. 11 indexed citations
19.
Guo, Xi, Hong Sun, Jihong Dong, et al.. (2019). Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 139. 16–23. 26 indexed citations
20.
Lin, Pingping, Xia Xu, Liang Liu, et al.. (2015). Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice. Biochemical and Biophysical Research Communications. 460(2). 362–367. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haochen Yu Breakdown of academic impact, for papers by Zhanzhao Fu Breakdown of academic impact, for papers by Min-Jung Kim Breakdown of academic impact, for papers by Hongliang Yu Breakdown of academic impact, for papers by Huizhen Zhang Breakdown of academic impact, for papers by Shuang Zhou Breakdown of academic impact, for papers by Dongha Kim Breakdown of academic impact, for papers by Michael J. Lukey Breakdown of academic impact, for papers by Paloma Navarro
Rankless by CCL
2026